Your Messages Inbox
Most Viewed Abstracts
1. Report Shows Shift in Starting Salaries for Physicians 2. 2008 Exclusive Survey—Earnings: Good news for primary care income 3. Medicare pay-for-reporting effort draws fire from frustrated doctors 4. Debunking Myths in the US Healthcare System 5. Statins and cancer risk
Your Article Summary
See Latest ArticlesAbbott Receives European Approval for Once-Daily Dosing of Kaletra Tablet
Abbott, 09/15/09
Abbott announced that it has received marketing authorization from the European Commission for once–daily dosing of the Kaletra tablet, the company’s leading HIV protease inhibitor, in adult patients new to HIV therapy. The Kaletra tablet is now approved for once–daily as well as twice–daily use in this patient population in combination with other antiretroviral agents, giving physicians another option when deciding on the most appropriate HIV dosing regimen.
Today in Dosing...keeping you current
Receive free subspecialty "5-minute updates" via email
Drug dosage protocol for calcium oxalate stone
Urological Research - Urolithiasis, 10/23/09
Risperidone dose for schizophrenia
Cochrane Reviews, 10/21/09
Telavancin: A Novel Lipoglycopeptide
Clinical Infectious Diseases, 11/16/09
Today in Drug Approvals...keeping you current
Receive free subspecialty "5-minute updates" via email
FDA Approves Gardasil to Prevent Genital Warts in Males. Agency Also Approves Bivalent HPV Vaccine for Girls, Young Women
American Family Physician, 10/22/09
Novartis receives FDA approval for Valturna®, a single-pill combination of valsartan and aliskiren, to treat high blood pressure
Novartis, 09/18/09
Salix Receives FDA Marketing Approval for Metozolv
Salix Pharmaceuticals, 09/10/09
Sponsor
Article Search
Sponsor